Investor mix
6 investors on record; lead investors include LLR Partners, Quaker Partners Management; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 17% |
| Private equity | 3 | 50% |
| Bank & private debt | 1 | 17% |
| Other / undisclosed | 1 | 17% |
Manufacturer of oncology based products and others generics
6 investors on record; lead investors include LLR Partners, Quaker Partners Management; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 17% |
| Private equity | 3 | 50% |
| Bank & private debt | 1 | 17% |
| Other / undisclosed | 1 | 17% |